Global Industry and Partnerships
Boston’s cannabis industry exists within a broader, growing, and global industry and cannabis ecosystem of policy, business, and innovation. Explore legal and emerging frameworks from jurisdictions around the world, and opportunities for knowledge exchange and cross-sector collaboration.
Africa
Ghana
Medical cannabis and industrial hemp permitted under licensing for low-THC cannabis cultivation and research.
Lesotho
One of Africa’s first countries to license commercial medical cannabis cultivation for export.
Malawi
Medical cannabis and industrial hemp cultivation are permitted under government licensing programs.
Morocco
Legalized cannabis cultivation for medical, pharmaceutical, and industrial uses under a regulated licensing framework.
Rwanda
Government approved cannabis cultivation for medical export under strict licensing.
South Africa
Private adult cultivation and possession are legal; the government is exploring commercial cannabis and hemp regulatory frameworks.
Uganda
Medical cannabis cultivation is allowed under strict government licensing for export markets.
Zambia
Licensed cannabis cultivation permitted for medical and export markets under government-issued permits.
Zimbabwe
Medical cannabis cultivation is legalized with government licensing for production and export.
Asia - Pacific
Australia
Federally regulated medical cannabis program with licensed cultivation, production, and prescription access for patients.
Japan
Cannabis prohibited under national law; recent reforms permit limited use of cannabis-derived pharmaceuticals under strict oversight.
New Zealand
National medical cannabis scheme permits licensed production and prescription access to cannabis medicines.
South Korea
Highly restricted medical cannabis access allowed through government-approved prescription import program.
Thailand
Decriminalized since 2022, Medical cannabis legal; since 2025 sales require a doctor’s prescription.
Vanuatu
Medical cannabis legalized with licensing framework.
Carribean
Barbados
Medical cannabis legal with regulated licensing for cultivation, processing, and medicinal product manufacturing.
Dominica
Medical cannabis legalized with regulated licensing supporting cultivation, production, and research activities.
Jamaica
Decriminalized cannabis with regulated medical and therapeutic licensing framework for cultivation and research.
Saint Kitts and Nevis
Medical cannabis legalized with licensing for cultivation, research, and regulated industry development.
Saint Vincent and the Grenadines
Medical cannabis legal with licensing for cultivation, processing, and export through a national authority.
Bermuda
Medical cannabis permitted; government exploring broader regulatory frameworks and commercial market development.
Europe
Austria
Medical cannabis permitted for pharmaceutical use; recreational use illegal. Small possession may be diverted to health authorities.
Belgium
Medical cannabis allowed in limited cases; CBD products regulated under national health authority.
Croatia
Medical cannabis permitted through prescription and pharmacy distribution.
Cyprus
Medical cannabis legal with licensed cultivation and pharmaceutical production.
Czech Republic
Medical cannabis legal; government advancing legislation toward a regulated adult-use market.
Denmark
Medical cannabis pilot program allows regulated cultivation, production, and prescriptions.
Estonia
Medical cannabis permitted through prescription under strict pharmaceutical regulation.
Finland
Medicinal cannabis requires special authorization from The Finnish Medicines Agency (Fimea), and it is only approved for specific, treatment-resistant conditions.
France
National medical cannabis pilot program testing regulated patient access.
Georgia
Personal cannabis use and possession legalized; commercial activity remains illegal.
Germany
Cannabis legalized for personal use, cultivation, and nonprofit social clubs; medical cannabis available under regulated framework.
Greece
Medical cannabis legal with licensed cultivation and pharmaceutical production.
Ireland
Medical Cannabis Access Programme permits limited patient access under specialist supervision.
Italy
Medical cannabis legal and produced through government-authorized cultivation for pharmaceutical use.
Lithuania
Medical cannabis legal through prescription medicines.
Luxembourg
Medical cannabis available via prescription; limited personal use and home cultivation permitted; no commercial retail market.
Malta
First EU country to legalize adult use; nonprofit cannabis associations regulated by national authority.
Netherlands
Cannabis retail allowed in licensed coffeeshops; medical cannabis regulated; government piloting legal cultivation.
North Macedonia
Medical cannabis program with licensed cultivation and production.
Norway
Medical cannabis permitted through prescription in limited circumstances.
Poland
Medical cannabis legal and available through prescription pharmacies.
Portugal
Medical cannabis legal with licensed cultivation and pharmaceutical distribution.
San Marino
Medical cannabis permitted through pharmacy distribution.
Slovenia
Medical cannabis permitted through pharmaceutical products
Spain
Cannabis social clubs operate regionally and private consumption is decriminalized; national medical cannabis framework under development.
Switzerland
Medical cannabis legal; cities running regulated adult-use pilot programs for research. Cannabis is decriminalized for private personal use and cultivation, while public consumption and commercial sale remain illegal.
Ukraine
Medical cannabis legalized in 2024 for treatment of certain conditions.
United Kingdom
Medical cannabis legal since 2018 but tightly restricted; access available through specialist prescriptions.
Latin America
Argentina
Since 2017, the country has approved the medical use of cannabis, and as of 2024, a licensing system allows for authorized cultivation and supply.
Brazil
Medical cannabis permitted via prescription; products imported or produced under approval from the national health regulator.
Chile
Medical cannabis allowed through prescriptions; cultivation permitted for approved research and patient programs. Growing at home for personal use is permitted, particularly with medical justification.
Colombia
Medical cannabis legal with licensed cultivation, manufacturing, and export under a national regulatory framework.
Costa Rica
Medical cannabis legalized with regulated cultivation and products.
Mexico
Medical cannabis legal; broader adult-use legalization legislation remains under consideration.
Panama
Medical cannabis legal; regulated licensing system governs cultivation, processing, and patient access.
Peru
Medical cannabis legal with regulated cultivation, production, and patient access through pharmacies.
Uruguay
First country to legalize cannabis nationally; regulated adult-use market includes pharmacies, home grow, and clubs.
North America
Canada
Cannabis is federally legal, with provincial and territorial regulation shaping retail, distribution, and public use rules.
Mexico
Cannabis is legal for medical use and decriminalized for personal adult use following Supreme Court rulings, but a fully regulated commercial market has not yet been established. Federal oversight is led by COFEPRIS under the Ministry of Health.
United States
State by state cannabis laws and regulatory frameworks. Federally Illegal.
Connect with us
Boston is committed to building meaningful connections across the global cannabis landscape. Interested in partnering, sharing information about your industry, or learning more? Connect with our team to explore opportunities for collaboration and global engagement.